Prevention of invasive fungal infections in patients with acute myeloid leukaemia: results of a single centre retrospective observational study with the use of posaconazole versus conventional mould-active azoles

被引：5
|
作者：
Dellacasa, Chiara Maria [1 ]
Busca, Alessandro [1 ]
Audisio, Ernesta [2 ]
Marmont, Filippo [2 ]
Barbui, Anna Maria [3 ]
Falda, Michele [1 ]
De Rosa, Francesco Giuseppe [4 ]
Frairia, Chiara [2 ]
Allione, Bernardino [2 ]
D'Ardia, Stefano [2 ]
Aydin, Semra [2 ]
Pecoraro, Clara [2 ]
Manetta, Sara [1 ]
Vitolo, Umberto [2 ]
机构：
[1] AO Citta Salute & Sci, SSCVD Trapianto Cellule Staminali Allogen, Turin, Italy
[2] AO Citta Salute & Sci, SC Ematol, Turin, Italy
[3] AO Citta Salute & Sci, SC Microbiol, Turin, Italy
[4] AO Amedeo Savoia, Dipartimento Sci Med, Turin, Italy
来源：
JOURNAL OF CHEMOTHERAPY | 2014年 / 26卷 / 05期
关键词：
CELL TRANSPLANT RECIPIENTS; ACUTE MYELOGENOUS LEUKEMIA; ANTIFUNGAL PROPHYLAXIS; HEMATOLOGIC MALIGNANCIES; CLINICAL EFFECTIVENESS; NEUTROPENIC PATIENTS; FLUCONAZOLE; ASPERGILLOSIS; ITRACONAZOLE; EPIDEMIOLOGY;
D O I：
10.1179/1973947813Y.0000000142
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：315 / 320
页数：6
相关论文
共 33 条
  • [1] Posaconazole vs. standard azoles for prevention of invasive fungal infections in patients with acute myeloid leukemia (AML)
    Busca, A.
    Frairia, C.
    Marmont, F.
    Audisio, E.
    Pecoraro, C.
    de Rosa, F. G.
    Allione, B.
    d'Ardia, S.
    Locatelli, F.
    Falda, M.
    MYCOSES, 2011, 54 : 92 - 92
  • [2] Invasive fusariosis in patients with leukaemia in the era of mould-active azoles: increasing incidence, frequent breakthrough infections and lack of improved outcomes
    Matsuo, Takahiro
    Wurster, Sebastian
    Jiang, Ying
    Sasaki, Koji
    Tarrand, Jeffrey
    Lewis, Russell E.
    Kontoyiannis, Dimitrios P.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (02) : 297 - 306
  • [3] Invasive Fungal Disease in Patients with Myeloid Malignancies: A Retrospective Cohort Study of a Diagnostic-Driven Care Pathway Withholding Mould-Active Prophylaxis
    De Kort, Elizabeth A.
    Buil, Jochem B.
    Schalekamp, Steven
    Schaefer-Prokop, Cornelia
    Verweij, Paul E.
    Schaap, Nicolaas P. M.
    Blijlevens, Nicole M. A.
    Van der Velden, Walter J. F. M.
    JOURNAL OF FUNGI, 2022, 8 (09)
  • [4] Epidemiology and outcomes of patients with invasive mould infections: a retrospective observational study from a single centre (2005-2009)
    Klingspor, Lena
    Saaedi, Baharak
    Ljungman, Per
    Szakos, Attila
    MYCOSES, 2015, 58 (08) : 470 - 477
  • [5] INVASIVE FUNGAL INFECTIONS IN FLT3-POSITIVE ACUTE MYELOID LEUKAEMIA PATIENTS TREATED WITH CHEMOTHERAPY AND MIDOSTAURIN: PRELIMINARY RESULTS OF A MULTICENTER OBSERVATIONAL SEIFEM STUDY
    Cattaneo, C.
    Marchesi, F.
    Bonuomo, V.
    Candoni, A.
    Pasciolla, C.
    Buzzatti, E.
    Dargenio, M.
    Mitra, M. E.
    Colnaghi, F.
    Prezioso, L.
    Busca, A.
    Rossi, G.
    Pagano, L.
    HAEMATOLOGICA, 2021, 106 (10) : 128 - 128
  • [6] A retrospective analysis of the posaconazole prevention for acute myeloid leukemia patients receiving induction chemotherapy-induced invasive fungal infection
    Wu, Chia-Hsuan
    Su, Hui-Chen
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 : S95 - S95
  • [7] Results from an observational study on primary prophylaxis of invasive fungal disease with posaconazole in patients with acute myelogenous leukemia
    Egerer, G.
    Harter, C.
    Gaul, S.
    Schmitt, T.
    Ehlken, B.
    Silberbach, K.
    Ho, A. D.
    ONKOLOGIE, 2010, 33 : 69 - 69
  • [8] PREVENTION AND TREATMENT OF INVASIVE FUNGAL INFECTIONS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES - RESULTS FROM A SINGLE HEMATOLOGICAL CENTRE
    Ivanyi, J. L.
    Plander, M.
    Szendrei, T.
    Toth, C.
    HAEMATOLOGICA, 2016, 101 : 765 - 765
  • [9] Posaconazole versus fluconazole or itraconazole for prevention of invasive fungal infections in patients undergoing intensive cytotoxic therapy for acute myeloid leukemia or myelodysplasia: a cost effectiveness analysis
    George Dranitsaris
    Haytham Khoury
    Supportive Care in Cancer, 2011, 19 : 1807 - 1813
  • [10] Posaconazole versus fluconazole or itraconazole for prevention of invasive fungal infections in patients undergoing intensive cytotoxic therapy for acute myeloid leukemia or myelodysplasia: a cost effectiveness analysis
    Dranitsaris, George
    Khoury, Haytham
    SUPPORTIVE CARE IN CANCER, 2011, 19 (11) : 1807 - 1813
1234